Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
No matches found
Show only India results
Show subsections
IND
USA
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
LUPIN LTD.
Lupin Ltd.
NSE: LUPIN | BSE: 500257
Mid-range Performer
Download real time
1946.60
-21.80
(
-1.11
%)
326.9K
NSE+BSE Volume
NSE
03 Jul, 2025 1:07 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
US FDA Approval
Lupin receives US FDA approval for its ANDA for Loteprednol Etabonate Ophthalmic Gel
See details
Overview
Buy Sell Zone
F&O
Financials
Forecaster
Competitors/Peers
Revenue Mix
Quarterly Results
Annual Results
Balance Sheet
Financial Ratios
Cash Flow
Documents
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents